Detailed company information
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q2Released: Aug 04, 2026
Earnings Transcript for 2026 - Q1Released: May 06, 2026
Earnings Transcript for 2025 - Q4Released: Feb 26, 2026
Earnings Transcript for 2025 - Q3Released: Nov 07, 2025
Earnings Transcript for 2025 - Q2Released: Aug 06, 2025
Earnings Transcript for 2025 - Q1Released: May 01, 2025
Earnings Transcript for 2024 - Q4Released: Feb 27, 2025
Earnings Transcript for 2024 - Q3Released: Oct 31, 2024
Earnings Transcript for 2024 - Q2Released: Aug 01, 2024
Earnings Transcript for 2024 - Q1Released: May 09, 2024
Earnings Transcript for 2023 - Q4Released: Feb 27, 2024
Earnings Transcript for 2023 - Q3Released: Nov 01, 2023
Earnings Transcript for 2023 - Q2Released: Aug 01, 2023
Earnings Transcript for 2023 - Q1Released: May 02, 2023
Earnings Transcript for 2022 - Q4Released: Feb 26, 2023
Earnings Transcript for 2022 - Q3Released: Oct 27, 2022
Earnings Transcript for 2022 - Q2Released: Jul 30, 2022
Earnings Transcript for 2022 - Q1Released: Apr 30, 2022
Earnings Transcript for 2021 - Q4Released: Feb 24, 2022
Earnings Transcript for 2021 - Q3Released: Oct 29, 2021
Earnings Transcript for 2021 - Q2Released: Jul 31, 2021
Earnings Transcript for 2021 - Q1Released: May 02, 2021
Earnings Transcript for 2020 - Q4Released: Feb 28, 2021
Earnings Transcript for 2020 - Q3Released: Nov 01, 2020
UTMD Utah Medical Products, Inc.